Seven Eight Capital LP Acquires Shares of 10,949 Maximus, Inc. (NYSE:MMS)

Seven Eight Capital LP bought a new stake in Maximus, Inc. (NYSE:MMS) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm bought 10,949 shares of the health services provider’s stock, valued at approximately $938,000.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. grew its position in Maximus by 2.4% in the 1st quarter. Vanguard Group Inc. now owns 6,208,839 shares of the health services provider’s stock valued at $520,922,000 after buying an additional 145,983 shares during the last quarter. Janus Henderson Group PLC boosted its holdings in shares of Maximus by 2.1% in the first quarter. Janus Henderson Group PLC now owns 1,254,536 shares of the health services provider’s stock valued at $105,255,000 after acquiring an additional 25,825 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Maximus by 7.4% in the second quarter. Dimensional Fund Advisors LP now owns 1,153,977 shares of the health services provider’s stock valued at $98,904,000 after acquiring an additional 79,092 shares in the last quarter. Van Berkom & Associates Inc. raised its holdings in Maximus by 0.8% during the second quarter. Van Berkom & Associates Inc. now owns 1,146,524 shares of the health services provider’s stock worth $98,257,000 after purchasing an additional 8,811 shares in the last quarter. Finally, Allspring Global Investments Holdings LLC lifted its position in Maximus by 0.5% in the first quarter. Allspring Global Investments Holdings LLC now owns 705,302 shares of the health services provider’s stock valued at $59,175,000 after purchasing an additional 3,680 shares during the period. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Price Performance

Shares of MMS opened at $89.98 on Friday. The firm has a market capitalization of $5.47 billion, a PE ratio of 23.62 and a beta of 0.76. The stock’s 50 day moving average is $89.80 and its two-hundred day moving average is $86.13. Maximus, Inc. has a twelve month low of $72.39 and a twelve month high of $93.97. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.61.

Maximus (NYSE:MMS) last released its quarterly earnings data on Wednesday, August 7th. The health services provider reported $1.74 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.47 by $0.27. The firm had revenue of $1.31 billion during the quarter, compared to analysts’ expectations of $1.29 billion. Maximus had a return on equity of 20.91% and a net margin of 5.59%. Maximus’s revenue was up 10.6% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.78 earnings per share. Research analysts anticipate that Maximus, Inc. will post 6.12 earnings per share for the current year.

Maximus Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Saturday, August 31st. Shareholders of record on Thursday, August 15th were given a dividend of $0.30 per share. The ex-dividend date of this dividend was Thursday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.33%. Maximus’s payout ratio is currently 31.50%.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.